PA
ENVA icon

PharVision Advisers’s Enova International ENVA Stock Holding History

PharVision Advisers’s Portfolio ENVA Stock Details ENVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,452
Closed -$282K – 774
2025
Q3 		$282K Buy
+2,452
New +$280K 0.16% 263
2025
Q2 		– Sell
-3,172
Closed -$306K – 317
2025
Q1 		$306K Buy
+3,172
New +$326K 0.42% 89

Other funds holding ENVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PharVision Advisers's ENVA Position: Q4 2025 in Review

PharVision Advisers sold out of Enova International (ENVA) in Q4 2025, closing a stake of 2,452 shares — an estimated $282K sold.

PharVision Advisers first reported a position in ENVA in Q1 2025 and held it in 2 quarters. The position peaked at $306K in Q1 2025. 387 funds tracked by Wall St. Rank hold ENVA as of Q4 2025.

  • PharVision Advisers reported no remaining Enova International position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 2,452 Enova International shares in Q4 2025, an estimated $282K.
  • PharVision Advisers first reported a position in Enova International in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Enova International position peaked at $306K in Q1 2025.
  • 387 funds tracked by Wall St. Rank held Enova International as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.